Research Updates: multiple sclerosis

Below are short extracts from research updates about this subject - select more to read each item.

  1. Issue 279

    HESAMIAN and ESKANDARI, 1 Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; 2 Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran,


  2. Issue 267

    NAJAFI and COLLEAGUES, 1. Department of Exercise Physiology, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran; 2. Department of Exercise Physiology, Shiraz Branch, Islamic Azad University, Shiraz, Ir1


  3. Issue 260

    HA SANPOUR DEHKORDI, 1. Department of Medical-Surgical, Faculty of Nursing and Midwifery, Shahrekord University of Medical Sciences, Shahrekord, Iran - conducted a 1


  4. Issue 258

    GODALA and COLLEAGUES, 1. Medical University of Lodz, Poland: Department of Hygiene of Nutrition and Epidemiology; 2. Medical University of Lodz, Poland: Department of Internal Diseases and Nephrodiabetology; 3. Medical University of Lo1


  5. Issue 257

    NAZARI and COLLEAGUES, Isfahan Neurosciences Research Centre, Department of Adult Health Nursing, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran, School of Nursing and Midwifery, Isfahan University of Medical 1


  6. Issue 255

    FOX and COLLEAGUES, 1. E.E. Fox, PhD, Faculty of Health and Human Science, Plymouth University, Plymouth, United Kingdom; 2. A.D. Hough, PhD, Faculty of Health and Human Science, Plymouth University; 3. S. Cre1


  7. Issue 251

    RIO and RUIZ-PEÑA, 1. Centre d'Esclerosi Múltiple de Catalunya (CEM-Cat), Servei de Neurologia-Neuroimmunologia, Hospital Universitari Vall d'Hebron, Psg. Vall d'Hebron 119-120, Barcelona 08035, Spain.


  8. Issue 249

    WANG and COLLEAGUES, 1. Center of Acupuncture and Moxibustion, Beijing Chinese Medicine Hospital Affiliated to Capital Medical University, Beijing 100010, China; 2. Department of Neurology, Dongfang Hospital Affiliated to Beijing University of CM; 31


  9. Issue 236

    WIPFLER and COLLEAGUES, (1)Department of Neurology, Christian-Doppler-Klinik, Paracelsus Medical University  and Salzburger Landeskliniken, Ignaz-Harrer-Strasse 79, 5020, Salzburg, Austria evaluated circadian rhythmicity of inflammatory serum p1


  10. Issue 236

    ROSTI-OTAJÄRVI and HÄMÄLÄINEN, (1)Department of Neurology and Rehabilitation, Tampere University Hospital, Finland. evaluated the prevalence of behavi1


  11. Issue 235

    GUNN and COLLEAGUES, (1)School of Health Professions, Plymouth University, Plymouth, UK evaluated the risk factors associated with falling in people with MS.


  12. Issue 235

    ZHORNITSKY and COLLEAGUES,  (1)Multiple Sclerosis Program, Department of Clinical Neurosciences, University of Calgary, Canada conducted a systematic review to examine the known associations between prolactin (PRL) and MS to elucidate its po1


  13. Issue 234

    TORKILDSEN and COLLEAGUES, (1)Department of Neurology, Norwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital, Bergen, Norway conducted a systematic search for vitamins in conjunction with 'multiple sclerosis', 'animal model' 1


  14. Issue 234

    MESLINIENE and COLLEAGUES, (1)Division of Endocrinology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL 32209, USA set out to review and assess the role of vitamin D in multiple sclerosis (MS).


  15. Issue 234

    MARTÍNEZ-SERNÁNDEZ and COLLEAGUES, (1)Department of Microbiology and Parasitology, Faculty of Pharmacy, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain. victoria.ma1


  16. Issue 232

    KAPLAN and COLLEAGUES, (1)Heller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer, Israel. the authors, in the search for new biomarkers for multiple sclerosis (MS), c1


  17. Issue 232

    EVANS and COLLEAGUES,  (1)Division of Neurology, University of British Columbia, Vancouver, B.C., Canada. conducted a comprehensive review examining the incidence and prevalenc1


  18. Issue 231

    ADELMAN and COLLEAGUES, (1)Fielding School of Public Health, University of California, Los Angeles, CA, USA estimate average annual cost per multiple sclerosis (MS) patient in the US using published estimates from the literature.


  19. Issue 230

    COSSU and COLLEAGUES, (1)Dipartimento di Scienze Biomediche, Sezione di Microbiologia Sperimentale e Clinica, Università di Sassari, Italy. conducted a clinical trial to study r1


  20. Issue 230

    MERO and COLLEAGUES,  (1)Department of Neurology, Oslo University Hospital, Ullevål, and Department of Medical Genetics, University of Oslo, Oslo, Norway searched for genetic differences in multiple sclerosis (MS) relating to the prese1


« Prev 1 2 3

ICAN Skyscraper

Scientific and Medical Network 2

Royal Rajasthan Cycle 2021

Amazon Wilderness Trek 2022

Cycle Kilimanjaro to the Coast 2022

top of the page